Geode Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Buy |
|
|||||
|
2025
Q1 | $1.88M | Buy |
|
|||||
|
2024
Q4 | $3.03M | Buy |
|
|||||
|
2024
Q3 | $2.97M | Buy |
|
|||||
|
2024
Q2 | $838K | Buy |
|
|||||
|
2024
Q1 | $662K | Buy |
|
|||||
|
2023
Q4 | $634K | Hold |
|
|||||
|
2023
Q3 | $526K | Buy |
|
|||||
|
2023
Q2 | $783K | Buy |
|
|||||
|
2023
Q1 | $271K | Hold |
|
|||||
|
2022
Q4 | $253K | Sell |
|
|||||
|
2022
Q3 | $244K | Hold |
|
|||||
|
2022
Q2 | $295K | Hold |
|
|||||
|
2022
Q1 | $489K | Buy |
|
|||||
|
2021
Q4 | $686K | Buy |
|
|||||
|
2021
Q3 | $1.02M | Buy |
|
|||||
|
2021
Q2 | $506K | Buy |
|
|||||
|
2021
Q1 | $458K | Buy |
|
|||||
|
2020
Q4 | $393K | Sell |
|
|||||
|
2020
Q3 | $447K | Sell |
|
|||||
|
2020
Q2 | $392K | Buy |
|
|||||
|
2020
Q1 | $293K | Buy |
|
|||||
|
2019
Q4 | $748K | Buy |
|
|||||
|
2019
Q3 | $389K | Buy |
|
|||||
|
2019
Q2 | $429K | Sell |
|
|||||
|
2019
Q1 | $654K | Buy |
|
|||||
|
2018
Q4 | $559K | Buy |
|
|||||
|
2018
Q3 | $1.1M | Buy |
|
|||||
|
2018
Q2 | $1.35M | Buy |
|
|||||
|
2018
Q1 | $875K | Buy |
|
|||||
|
2017
Q4 | $766K | Buy |
|
|||||
|
2017
Q3 | $1.17M | Buy |
|
|||||
|
2017
Q2 | $832K | Buy |
|
|||||
|
2017
Q1 | $842K | Buy |
|
|||||
|
2016
Q4 | $543K | Buy |
|
|||||
|
2016
Q3 | $606K | Buy |
|